Arcus Biosciences, Inc.

ABOUT

Arcus Biosciences is a rapidly growing, clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines that may have the potential to help people with cancer live longer.

Located in the San Francisco bay area, Arcus Biosciences offers a competitive compensation and benefits package, including aggressive participation in the growth of the company in the form of stock option grants. Arcus has an ambitious undertaking and expects to become a force in the discovery, development and commercialization of novel combination therapies to treat cancer in areas of high unmet need. Our employees enjoy operating in an exceptionally dynamic and team-driven environment in which the “rule book” has not yet been written.

3928 Point Eden Way, Hayward, CA 94545 1800 Sierra Point Parkway, Brisbane, CA 94005 US
NEWS
Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing.
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
AWARDS
  • NextGen Class of 2017
JOBS
IN THE PRESS